Novartis
-
{
- All
- News
- Videos
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
-
Just Approved Gene Therapy Drug Is World's Most Expensive At $2.1 Million
The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants.
-
Swiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For Malaria
Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.
-
Ten Greek Ex-Ministers Allegedly Involved In Novartis Bribery Probe
Two former Greek prime ministers and eight former ministers have been implicated in an alleged corruption scandal involving Swiss pharmaceutical giant Novartis, a judicial source said Monday.
-
India-Origin Vasant Narasimhan Named CEO Of Novartis
Vasant Narasimhan is among a new generation of leaders at Novartis who have sought to improve the process in which drugs move from research to actually becoming a commercial product.
-
Drug Defies A Rare Form Of Cancer - And Market Logic
When the drug company Novartis launched its breakthrough cancer medicine, Gleevec, in 2001, the list price was $26,400 a year. The company's chief executive acknowledged it was expensive, calling it an "uphill battle to win understanding for our decision."
-
Novartis Digs Into Health Tech With Bet on 'Robotic Pill'
The Rani capsule contains tiny needles made of sugar that are pushed into the wall of the intestine to deliver the drug.
-
Novartis Japan Hit With Suspension Over Side-Effect Reporting
Japanese health authorities said today that they have ordered the local unit of Swiss pharmaceutical giant Novartis to temporarily suspend its operations for failing to report drug side effects.
-
Heart Drug Could Be "Most Exciting Ever", Says Novartis
Swiss drugmaker Novartis has unveiled strikingly good clinical trial results for a new heart failure drug that might be the biggest pharmaceutical advance in a quarter of century.
-
Novartis and Google to Develop 'Smart' Contact Lens
Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
-
Google, Norvartis Partner on Medical Applications of Smart Contact Lenses
Google's devoted unit to new solutions and Novartis' eye care division Alcon will work together for this project.
-
US sues Novartis over kickbacks, second case this week
The US government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescribing its drugs.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
-
Just Approved Gene Therapy Drug Is World's Most Expensive At $2.1 Million
The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants.
-
Swiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For Malaria
Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.
-
Ten Greek Ex-Ministers Allegedly Involved In Novartis Bribery Probe
Two former Greek prime ministers and eight former ministers have been implicated in an alleged corruption scandal involving Swiss pharmaceutical giant Novartis, a judicial source said Monday.
-
India-Origin Vasant Narasimhan Named CEO Of Novartis
Vasant Narasimhan is among a new generation of leaders at Novartis who have sought to improve the process in which drugs move from research to actually becoming a commercial product.
-
Drug Defies A Rare Form Of Cancer - And Market Logic
When the drug company Novartis launched its breakthrough cancer medicine, Gleevec, in 2001, the list price was $26,400 a year. The company's chief executive acknowledged it was expensive, calling it an "uphill battle to win understanding for our decision."
-
Novartis Digs Into Health Tech With Bet on 'Robotic Pill'
The Rani capsule contains tiny needles made of sugar that are pushed into the wall of the intestine to deliver the drug.
-
Novartis Japan Hit With Suspension Over Side-Effect Reporting
Japanese health authorities said today that they have ordered the local unit of Swiss pharmaceutical giant Novartis to temporarily suspend its operations for failing to report drug side effects.
-
Heart Drug Could Be "Most Exciting Ever", Says Novartis
Swiss drugmaker Novartis has unveiled strikingly good clinical trial results for a new heart failure drug that might be the biggest pharmaceutical advance in a quarter of century.
-
Novartis and Google to Develop 'Smart' Contact Lens
Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
-
Google, Norvartis Partner on Medical Applications of Smart Contact Lenses
Google's devoted unit to new solutions and Novartis' eye care division Alcon will work together for this project.
-
US sues Novartis over kickbacks, second case this week
The US government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescribing its drugs.
